Keywords: teva, invests, clal, curetech, opens, jerusalem, plant

Teva invests in Clal and CureTech; opens Jerusalem plant

Article | 19 September 2005

Print This

Teva Pharmaceutical Industries is to pay $19.0 million to acquire a 19% stake in the biotechnology division of fellow Israeli holding firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in